Daily Stock List
LKA Gold, Inc. (LKAI)
BestDamnPennyStocks, DSR News, PHUB NEWS, TheNextBigTrade, TopPennyStockMovers, Penny Stocks VIP, Penny Pick Insider, Daily Stock Motion, Gryphon Digest, PennyStocks24, 007 Stock Chat, PennyStockSpy, OtcShortReport, and Information Solutions Group reported earlier on LKA Gold, Inc. (LKAI), and we report on the Company today, here at the QualityStocks Daily Newsletter.
LKA Gold, Inc.’s focus is on acquiring and developing properties in politically stable jurisdictions that can yield high profit margins even during volatile economic conditions. The Company’s Golden Wonder mine has a recent production history of 141,510 ounces of gold at an average ore grade of 11.63 ounces (362 grams) gold per ton and an average production cost of less than $150 per ounce. Golden Wonder is a very high-grade telluride (epithermal) gold deposit. LKA Gold is based in Gig Harbor, Washington.
Golden Wonder is located near Lake City, Colorado. The average grade of Golden Wonder ore (from 1998, through the second quarter of 2006) was 16.01 ozs. (454 grams) gold per ton. LKA’s belief is that additional such ore chutes may be on its mining claims.
Since restarting exploratory operations in Q1 2009, LKA Gold has shipped 27 bulk ore samples containing over 4,000 ounces of gold with a net value, after processing, of more than $4.2 million. LKA is continuing to evaluate financing options to expand/accelerate this program. A commercially viable ore reserve has yet to be established.
In July of 2015, LKA Gold announced that it executed an "Exploration Agreement & Option" with Kinross Gold USA Inc. for expanding its Golden Wonder Mine exploration beyond LKA's active workings. This Agreement, among its other provisions, grants Kinross Gold USA a five-year exclusive right to explore, and if successful, develop any mineral resource(s) containing 50,000 or more ounces of gold on LKA Gold's properties above and next to the Golden Wonder Mine.
Kinross Gold USA conducted a detailed evaluation of surface geology surrounding LKA's Golden Wonder mine. A report detailing Kinross' findings, earlier provided to LKA, indicates a number of prospective targets possessing similar characteristics to those found on surface above the earlier mined high-grade ore shoot.
This past December, LKA Gold announced that a Kinross Gold USA sponsored and directed surface drilling program is taking place at the first of four permitted sites situated on LKA mining claims very near the Company's Golden Wonder mine.
The drilling program began in late November 2016. The design of this program is to test four of six areas, earlier identified by Kinross Gold geologists, possessing geochemistry like that of the initial bonanza-grade discovery at LKA's Golden Wonder mine.
LKA Gold, Inc. (LKAI), closed Tuesday's trading session at $0.304, down 43.69%, on 7,584 volume with 6 trades. The average volume for the last 60 days is 9,336 and the stock's 52-week low/high is $0.20/$0.68.
Calmare Therapeutics, Inc. (CTTC)
TaglichBrothers, OTCBB Journal, and SmallCapVoice reported earlier on Calmare Therapeutics, Inc. (CTTC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Calmare Therapeutics, Inc. (the Calmare Pain Mitigation Therapy™ company) researches, develops, and commercializes chronic, neuropathic pain, and wound affliction devices. Calmare devices sell commercially to medical practices globally. Moreover, they are found in U.S. military hospitals, clinics, and on installations through the Company’s General Services Administration (GSA) military contract (V797P-4300B). Calmare Therapeutics has licensed over 500 technologies to more than 400 individual organizations. Calmare Therapeutics is based in Fairfield, Connecticut.
The Company’s medical devices provide a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. Calmare supplements its medical devices with a catalogue of private label neurostimulation and sensory electrodes.
Calmare creates partnerships with its clients and customers to maximize their Intellectual Property (IP) assets, reduce time-to-market, and add to their profitability. The Company’s Technology Sourcing Service looks for technologies that fit with customer business goals and presents them as potential licensing or IP acquisition candidates.
Calmare Therapeutics has been a preferred vendor of the U.S. federal government (GSA#V797P-4300b) since 2010. Devices, consumables and related hardware sell to U.S. military hospitals and clinics throughout the U.S. The Company sells its devices in Europe under CE-mark designation.
The Company’s flagship medical device is the Calmare® Pain Therapy Device. This is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. Calmare Therapeutics holds a U.S. Food & Drug Administration (FDA) 510k clearance designation (K081255) on its flagship device. This grants it the exclusive right to sell, market, research, and develop the medical device in the U.S.
Regarding CALMARE® Pain Therapy Treatment, the device is FDA-cleared for U.S. sales, U.S. patented and patent pending in other countries, and medically certified in Europe. The Calmare® Pain Therapy Device treats oncologic and neuropathic pain via a biophysical rather than biochemical approach.
In January 2017, Calmare Therapeutics reported results for the three-months and nine-months ended September 30, 2016. Revenues from the commercial sale and shipment of Calmare® pain therapy devices for the three months ended September 30, 2016 were $465,000, versus $197,000 for the three months ended September 30, 2015.
Net loss for the three months ended September 30, 2016 was $648,000 or $0.02 per basic and diluted share, versus a net loss of $1,063,000 or $0.04 for the three months ended September 30, 2015.
Revenues from the commercial sale and shipment of Calmare® pain therapy devices for the nine months ended September 30, 2016 were $716,000, versus $405,000 for the nine months ended September 30, 2015. Net loss for the nine months ended September 30, 2016 was $2,638,000 or $0.09 per basic and diluted share, versus a net loss of $2,846,000 or $0.10 for the nine months ended September 30, 2015.
Calmare Therapeutics, Inc. (CTTC), closed Tuesday's trading session at $0.125, up 32.55%, on 88,500 volume with 13 trades. The average volume for the last 60 days is 24,608 and the stock's 52-week low/high is $0.0845/$0.27.
Saint Jean Carbon, Inc. (TORVF)
Greenbackers and Information Solutions Group reported previously on Saint Jean Carbon, Inc. (TORVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Saint Jean Carbon, Inc. is a carbon science company that has specific interests in energy storage and green energy creation and green re-creation. The Company has holdings in graphite mining and lithium claims in Quebec. Saint Jean Carbon’s main office is in Calgary, Alberta. Its executive office is in Oakville, Ontario. As of February 2, 2017, Saint Jean Carbon commenced trading on the OTC Markets Group’s OTCQB under the symbol TORVF.
The Company’s Graphite properties include Walker Lump, Clot Lump, St. Jovite Lump, and the Bell Project. The Walker Mine property comprises 4 claims covering the past mine, and 11 claims covering interesting geological context for more graphite mineralization in the area around the deposit.
The Clot Graphite Project is in Joly Township, roughly 150 kms northwest of Montreal. It comprises 5 claims, which encompasses an area of approximately 297.35 hectares (ha) (735 acres); and 3 additional claims in demand that will be transferred to Saint Jean Carbon as soon as the M.E.R.N.Q. has approved the attribution.
The St. Jovite Lump Graphite Project is 8.5 km south-southeast of the village of Brebeuf, in the Laurentian region, roughly 153 km northwest of Montreal. It consists of a vein type deposit with the most important pegmatitic vein measuring 30 m in length by 0.6 to 1.8 m in width.
Furthermore, the Company’s Bell Mine property consists of 13 claims (CDC) for a total area of 781 ha. It is on Buckingham and Lochaber Townships in southwestern Quebec, around 170 km west of Montreal.
Saint Jean Carbon also has its Whabouchi Lithium Project. It entered into an agreement to acquire the Whabouchi Lithium Project in the James Bay region of Quebec. The Property lies roughly 45 kms southeast of the village of Nemaska that is linked by a network of all-season roads to the mining center of Chibougamau, 300 kms to the south.
The Company also has its High Rock Island Project. Gold mineralization in quartz veins occurs on Highrock Island. The gold mineralization on Highrock Island and surrounding region is coarse gold, irregularly distributed in the quartz veins. While one sample may return a very high assay, the sample next to it may contain no gold. This is a phenomenon called the “nugget effect”.
Last week, Saint Jean Carbon announced that it set the preliminary numbers for the graphene battery project announced on January 18, 2017. The preliminary performance markers will be used to judge performance for and against the three prototype graphene batteries in production. It hopes to have the final batteries results ready within three weeks. Saint Jean Carbon is continuing with the recycled battery project. Also, the final spherical carbon coated graphite specifications and performance results are expected very soon.
Today, Saint Jean Carbon announced that it received its initial order from Panasonic Corporation to supply graphite anode material to its manufacturing facility. The order consists of two different material specifications. Panasonic is one of the largest battery manufacturers in the world.
Saint Jean Carbon, Inc. (TORVF), closed Tuesday's trading session at $0.14, up 125.81%, on 1,284,463 volume with 123 trades. The average volume for the last 60 days is 61,042 and the stock's 52-week low/high is $0.0213/$0.063.
Advanced BioMedical Technologies, Inc. (ABMT)
We are reporting on Advanced BioMedical Technologies, Inc. (ABMT) today, here at the QualityStocks Daily Newsletter.
Advanced BioMedical Technologies, Inc. manufactures and distributes advanced impedance controlled micro-current instruments. The Company is the only distributor of the Electro-Acuscope, Electro-Myopulse models that has a 6,000-square foot center that offers treatment, training, research and instrument sales and support. Advanced BioMedical Technologies’ shares trade on the OTC Markets Group’s OTCQB.
The Electro-Acuscope and Electro-Myopulse instruments feature the most sophisticated computerized, feedback-controlled, energy delivery, micro-current technology available today. Advanced BioMedical Technologies has treated more than 15,000 patients during the past 28 years. The Company has a complete staff of qualified professionals fully trained on the aforementioned leading-edge technology.
Acuscope products include the Electro-Acuscope 85P (Portable); the Electro-Acuscope 80L; and the Neuroscope 230B. Myopulse products include the Electro-Myopulse 75L (Base Model) and the Electro-Myopulse 75F (used in Fermi Lab Study).
In addition, Advanced BioMedical Technologies has its La Fleur products. This includes the Electro-Myopulse 75LN Premium Instrument (Myopulse, Facial and Esthetics), which was developed exclusively by the Company. Furthermore, Advanced BioMedical Technologies carries a line of Accessories.
The Electro-Acuscope monitors nerve conduction between two electrodes. This is how the current amplitude and voltage output is adjusted and controlled. The Acuscope uses a complex waveform. This waveform imitates a nerve impulse.
The Electro-Myopulse measures the Bio-Impedance of the muscle tissue between the two electrodes. Likewise, this is how the current amplitude and voltage output is adjusted and controlled. The Myopulse uses a sine wave. This sine wave imitates the wave produced when a muscle first contracts.
The design of the Electro-Acuscope 85P (Portable) instrument is for the traveling clinician or patient (with prescription). This instrument is built into a haliburtor case for safe and easy portability.
The Company’s Neuroscope 230B (Home Care Unit) is for personal treatment of sleep, anxiety, and also pain issues. This product is a personal treatment device for the person on the go. It is also as an adjunct to Acuscope and Myopulse (impedance controlled microcurrent) therapy where extended rehabilitation therapy necessitates additional treatments at home.
Advanced BioMedical Technologies, Inc. (ABMT), closed Tuesday's trading session at $0.20, up 100.00%, on 500 volume with 1 trade. The average volume for the last 60 days is 769 and the stock's 52-week low/high is $0.10/$0.25.
Tiger Reef, Inc. (TGRR)
We are reporting on Tiger Reef, Inc. (TGRR) today, here at the QualityStocks Daily Newsletter.
Tiger Reef, Inc. is a diversified producer of ultra premium rums under the Tiger Reef® brand. In addition, the Company is a developer of casual dining restaurant properties in the Caribbean. The Company previously went by the name Blue Water Bar & Grill, Inc. It changed its corporate name to Tiger Reef, Inc. in October of 2016.
Tiger Reef lists on the OTC Markets Group’s OTCQB. Established in 2013, Tiger Reef has its headquarters in Cole Bay, the Netherlands Antilles. The Company is a subsidiary of BWG Investments & Development, Ltd.
Today, Tiger Reef announced that it has developed a new upscale casual dining restaurant concept The Company has branded this concept as Mermaid Reef Ocean Grill & Bar (Mermaid Reef). The Mermaid Reef concept is an intimate restaurant of between 60 to 80 seats and has indoor and outdoor seating.
Each restaurant will be built on-site at an existing major Caribbean resort chain. Although it will be operated as a resort amenity, each restaurant will also be actively marketed to non-resort guests as well as local residents.
At present, Tiger Reef is in advanced negotiations to build the first Mermaid Reef in a major Caribbean resort located on the island of St. Maarten, Dutch West Indies. The Company says that this particular resort operator has a number of additional resort properties situated throughout the Caribbean where the Mermaid Reef concept could be expanded to in the future.
Tiger Reef says that it anticipates completing negotiations and executing a definitive lease agreement within the next 60 days. At that time, the Company will disclose the name and exact location of the resort property.
Upon successfully demonstrating proof of concept with this first St. Maarten location, Tiger Reef’s intention is to open one new Mermaid Reef restaurant on-site at a major Caribbean resort property each year moving ahead.
Tiger Reef, Inc. (TGRR), closed Tuesday's trading session at $0.12, up 9.09%, on 12,400 volume with 4 trades. The average volume for the last 60 days is 4,340 and the stock's 52-week low/high is $0.013/$0.86.
The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.129, off by 8.21%, on 222,63 volume with 228 trades. The stock’s average daily volume over the past 60 days is 181,891 and its 52-week low/high is $0.12/$2.75.
ChineseInvestors.com, Inc. today announced its management team will be presenting at the National Investment Banking Association Conference in New York City on February 28, 2017. The conference location is at the Westin New York Grand Central Hotel on 42nd Street and 3rd Avenue in Midtown Manhattan. The Company presents in the morning on February 28th.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer
ChineseInvestors.com, Inc. to Present at the National Investment Banking Association Conference in New York City on February 28, 2017
ChineseInvestors.com Presents at Yibao Biologics' Annual Conference, Optimistic About Direct Selling Opportunity in China
Stealth Technologies Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0785, up 18.76%, on 12,124,634 volume with 792 trades. The stock’s average daily volume over the past 60 days is 8,238,037, and its 52-week low/high is $0.0055/$0.142.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
SinglePoint, Inc. Featured on MoneyTV with Donald Baillargeon, 2/17
SinglePoint Diversifies Operations & Solidifies Financials -- CFN Media
NetworkNewsWire Releases Exclusive Audio Interview with SinglePoint, Inc. (SING)
ORHub, Inc. (ORHB)
The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.85, up 8.97%, on 300,832 volume with 111 trades. The stock’s average daily volume over the past 60 days is 15,174 and its 52-week low/high is $0.05/$2.09.
ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.
The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.
Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.
Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.
In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.
ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.
The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.
ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.
Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer
ORHub, Inc. Blog
ORHub, Inc. News:
ORhub, Inc. (ORHB) Engages NetworkNewsWire for Corporate Communications Solutions
ORHub, Inc. (ORHB) Expands Operations at Nation's Second Largest Non-Profit Hospital System
ORHub, Inc. (ORHB) Featured in NetworkNewsWire's NetworkNewsBreaks, Top 10 Mid-day Percentage Gainers, Feb 14
GreenStone Healthcare Corp. (GRST)
The QualityStocks Daily Newsletter would like to spotlight GreenStone Healthcare Corp. (GRST). Today, GreenStone Healthcare Corp. closed trading at $0.0699, off by 0.36%, on 65,500 volume with 10 trades. The stock’s average daily volume over the past 60 days is 39,476, and its 52-week low/high is $0.015/$0.083.
GreenStone Healthcare Corp. (GRST), through its subsidiaries, provides medical services in the city of Toronto and the regional municipality of Muskoka, Ontario, Canada.
Located 90 minutes north of Toronto in Muskoka, GreenStone Healthcare's Addiction and Rehabilitation Treatments segment offers out-patient counseling, coaching, intervention, psychological assessment, and other related services.
GreeneStone Muskoka employs the best principles and practices currently available in the treatment of individuals with addiction. To ensure the most comprehensive and effective treatment for its clients, GreenStone Muskoka treats underlying or co-occurring disorders in tandem with the treatment of addiction.
The 36-bed addiction treatment center offers a holistic, individualized treatment approach to recovery. These private, paid programs vary in length from 45-90 days, depending on the unique needs of each resident and their response to the treatment.
GreenStone Muskoka also provides education and counseling sessions to educate the family members of its residents with the objective of helping them better understand the disease of addiction and how they should support their loved one throughout and after their recovery efforts.
GreenStone Healthcare President Shawn Leon has more than 25 years of experience managing public and private development-stage companies for various industries, including industrial minerals, aggregates, oil and gas, mining, financial, technology, hospitality and medical. He has provided financing and capital markets oversight for a number of these ventures, many of which have involved negotiations for mergers and acquisitions. He is joined by Vice President Dr. Anita Teslak, whose 25 years of combined experience as a CEO, psychologist and leadership provides valuable insight into a successful business model. Disclaimer
GreenStone Healthcare Corp. Company Blog
GreenStone Healthcare Corp. News:
GreeneStone Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
GreeneStone Signs Definitive Agreement to Acquire Seastone of Delray, a Florida Limited Liability Company
GreeneStone Signs LOI to Acquire Aurora Recovery
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.71, up 2.62%, on 15,768 volume with 19 trades. The stock’s average daily volume over the past 60 days is 12,583, and its 52-week low/high is $0.7094/$5.84.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp World Holdings to Present at Annual ROTH Conference
Super Bowl Quarterback Vince Ferragamo Joins eXp Realty
eXp World Holdings, Inc. to Host Corporate Update Webinar on February 23rd
Today's Top 3
Profitable Trader Authority
Penny Stock Prodigy
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- ChineseInvestors.com, Inc. (CIIX) to Present at the National Investment Banking Association Conference in New York City on February 28, 2017
- Dominovas Energy Corp. (DNRG) Enters Formal Negotiations to Open in India and Indonesia
- eXp World Holdings, Inc. (EXPI) to Present at Annual ROTH Conference
- GreenStone Healthcare Corp. (GRST) Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
- Monaker Group, Inc. (MKGI) Appoints Robert Post to Board of Directors
- National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling
- ORHub, Inc. (ORHB) Engages NetworkNewsWire for Corporate Communications Solutions
- Players Network (OTCQB: PNTV) Featured on MoneyTV with Donald Baillargeon, 2/17
- Singlepoint, Inc. (SING) NetworkNewsWire Releases Exclusive Audio Interview with SinglePoint
- Stealth Technologies, Inc. (STTH) Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference